title: Ex vivo evaluation of the NASA/DeBakey axial flow ventricular assist device. Results of a 2 week screening test.
abstract: The authors investigated the antithombogenicity of the NASA/DeBakey axial flow ventricular assist device in an ex vivo calf model. The device is 3 inches in length and 1 inch in largest diameter. The pump weighs 53 g and displaces 15 ml. The unit consists of three major components: a flow straightener, a spinning inducer/impeller, and a diffuser. The impeller has rod shaped permanent magnets embedded within the six blades and is activated magnetically by a motor stator that is positioned outside the flow tube. Previous 2 day screening tests demonstrated an antithrombogenic configuration in short-term implantation. Based on the results of these 2 day screening tests, five pumps with the best configuration were implanted into a calf for 2 weeks for anti thrombogenicity confirmation. Pumps were implanted paracorporeally, and heparin was used to maintain activated clotting time to approximately 250 sec. Each pump was changed every 2 weeks as planned. During the experiment, all pumps demonstrated stable pumping. The required electric power was 7 to 8 watts and pump flow was maintained at 4 L/min. The calf was in excellent condition. Liver and renal function were maintained, plasma free hemoglobin was kept at less than 4 mg/dl (3.3 +/- 0.3 mg/dl), and lactate dehydrogenase was 1043 +/- 36 units/L. In this experimental series, all five pumps passed the 2 week implantation. Two week ex vivo test results indicated very slight thrombus in the hub areas of some pumps. For the next phase of the implantation study, minor design optimization is necessary to completely eliminate thrombus formation. According to our step by step approach, the in vivo test aiming for long-term implantation is ongoing.
authors.affiliation: Baylor College of Medicine, Department of Surgery, Houston, TX 77030, USA.
authors.forename: K
authors.initials: K
authors.lastname: Kawahito
authors.forename: R
authors.initials: R
authors.lastname: Benkowski
authors.forename: S
authors.initials: S
authors.lastname: Otsubo
authors.forename: B
authors.initials: B
authors.lastname: Rosenbaum
authors.forename: R
authors.initials: R
authors.lastname: Moreland
authors.forename: G P
authors.initials: GP
authors.lastname: Noon
authors.forename: Y
authors.initials: Y
authors.lastname: Nosé
authors.forename: M E
authors.initials: ME
authors.lastname: Debakey
mesh_terms: D000818:Animals; D002417:Cattle; D003404:Creatinine / Q000378:metabolism; D004867:Equipment Design; D005069:Evaluation Studies as Topic; D006353:Heart-Assist Devices / Q000009:adverse effects; D006454:Hemoglobins / Q000378:metabolism; D006461:Hemolysis; D006801:Humans; D066298:In Vitro Techniques; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors
chemical_list: D006454:Hemoglobins; D003404:Creatinine; D007770:L-Lactate Dehydrogenase